High Comorbidity in Premature Infant: Abdominal Aortic Thrombosis, Wolff-Parkinson-White Syndrome, Secondary Hypothyroidism
https://doi.org/10.15690/pf.v20i1.2524
Abstract
Background. Neonatal thromboses, both venous and arterial, are a rare pathology, and experience in systemic thrombolysis is very low. Thus, the methods of adult management are currently being adapted to pediatric practice.
Clinical case description. This report describes clinical case of abdominal aortic thrombosis in a premature infant with later diagnosed Wolff-ParkinsonWhite syndrome and acquired hypothyroidism developed due to antiarrhythmic therapy.
Conclusion. The premature boy had high comorbidity that required many specialists’ involvement. Timely systemic thrombolytic therapy and antiarrhythmic drugs selection made it possible to save the child's life and most likely to avoid disability in the future.
About the Authors
Alena S. TikhonovaRussian Federation
1, b. 7, Ostrovityanova Str., Moscow, 117997
Disclosure of interest:
Not declared.
Anastasiya M. Kozlova
Russian Federation
Moscow
Disclosure of interest:
Not declared.
Anna A. Tsaturova
Russian Federation
Moscow
Disclosure of interest:
Not declared.
References
1. Bokaryov IN, Popova LV. Modern problems of arteries and veins thromboses. Practical Medicine. 2014;(6):13–17. (In Russ).
2. Svirin PV, Roumiantsev SA, Larina LE, et al. Neonatal thrombosis: treatment regimen. Neonatology. News. Opinions. Training. 2013;(1):76–85. (In Russ).
3. Shaik M, Patel D, Mihir B, et al. Epidemiology, Diagnosis and Management of Neonatal Thrombosis. Blood. 2019;134(Suppl 1):3656. doi: https://doi.org/10.1182/blood-2019-129914
4. Dieffenbach BV, Nath BD, Tracy ET, Kim HB. Management of symptomatic neonatal aortic thrombosis: When is surgery indicated? J Pediatr Surg Case Rep. 2019;47:101247. doi: https://doi.org/10.1016/j.epsc.2019.101247
5. Chhabra L, Goyal A, Benham MD. Wolff Parkinson White Syndrome. [Updated 2022 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
6. Dzhanashiya PKh, Shevchenko NM, Ryzhova TV. Rol’ amiodarona v lechenii aritmii. Lechaschi Vrach. 2006;(3). (In Russ). https://www.lvrach.ru/2006/03/4533545.
7. Mkrtumyan AM, Biryukova YeV, Yegshatyan LV, et al. Amiodarone-Induced Thyrotoxicosis Type 1: Features of Patient Management. Effektivnaya farmakoterapiya. 2019;15(25):8–11. (In Russ). doi: https://doi.org/10.33978/2307-3586-2019-15-25-8-11
8. Starodubova AV. Amiodaron. Chto dolzhen znat’ praktikuyushchii vrach. AtmosferA. Novosti kardiologii. 2011;(1):19– 25. (In Russ).
9. Narayana SK, Woods DR, Boos CJ. Management of amiodarone-related thyroid problems. Ther Adv Endocrinol Metab. 2011;2(3):115–126. doi: https://doi.org/10.1177/2042018811398516
10. Danzi S, Klein I. Amiodarone-induced thyroid dysfunction. J Intensive Care Med. 2015;30(4):179–185. doi: https://doi.org/10.1177/0885066613503278
11. Lebedeva EA, Iablonskaia IA, Bulgakova SV. Amiodarone-induced thyrotoxicosis: state of the art. Clinical and experimental thyroidology. 2017;13(2):31–38. (In Russ). doi: https://doi.org/10.14341/ket2017231-38
Review
For citations:
Tikhonova A.S., Kozlova A.M., Tsaturova A.A. High Comorbidity in Premature Infant: Abdominal Aortic Thrombosis, Wolff-Parkinson-White Syndrome, Secondary Hypothyroidism. Pediatric pharmacology. 2023;20(1):59-62. (In Russ.) https://doi.org/10.15690/pf.v20i1.2524